As of April 16, 2025, Calliditas Therapeutics (CALT) has a market cap of $1.10 billion USD. According to our data, Calliditas Therapeutics is ranked No.4904 in global market value.
Year | Market Cap | %Change |
---|---|---|
Sep 27, 2024 | $1.10 B |
55.38%
|
Dec 29, 2023 | $0.70 B |
51.44%
|
Dec 30, 2022 | $0.46 B |
-31.34%
|
Dec 31, 2021 | $0.67 B |
-26.35%
|
Dec 31, 2020 | $0.91 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Omeros Corporation
OMER
|
$0.40 B |
-0.000 M
|
![]() USA
|
![]() Travere Therapeutics
TVTX
|
$1.32 B |
-0.000 M
|
![]() USA
|
![]() Akebia Therapeutics
AKBA
|
$0.49 B |
-0.000 M
|
![]() USA
|
![]() Aurinia Pharmaceuticals
AUPH
|
$1.06 B |
0.000 M
|
![]() Canada
|
![]() FibroGen
FGEN
|
$29.89 M |
0.000 M
|
![]() USA
|
![]() Prothena
PRTA
|
$0.52 B |
-0.000 M
|
![]() Ireland
|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.55 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
Market Cap | = | CALT Stock Price | * | CALT Shares Outstanding |
= | $40.00 | * | 27.02 M | |
= | $1.10 B |